U.S. Consumer Finance Stock News

Blue Owl Capital (OWL) is under close watch after concerns about AI related disruption in software lending coincided with its latest quarterly earnings and dividend declaration, placing the focus squarely on credit quality and fundraising resilience. See our latest analysis for Blue Owl Capital. That backdrop has been reflected in the share price, with a 1 day share price return of 7.65% after earnings and dividend news, but a 30 day share price return showing a 20.41% decline and a 1 year...

Why Envista’s latest earnings matter for investors Envista Holdings (NVST) has just reported fourth quarter and full year 2025 results that came in ahead of Wall Street expectations, alongside 2026 guidance that points to further revenue and EBITDA growth. The company moved from a large loss in 2024 to a profit in 2025, with management linking this shift to broad based contributions across its business units, new product launches and tighter operational efficiency. See our latest analysis for...

The Ensign Group recently reported Q4 and full-year 2025 results, posting US$1,360.63 million in quarterly revenue and diluted EPS of US$1.61, while issuing 2026 guidance of US$7.41–US$7.61 per diluted share on US$5.77–US$5.84 billion of revenue. Alongside the earnings update, Ensign accelerated its expansion by adding several skilled nursing facilities across multiple states, bringing its portfolio to 378 healthcare operations and 160 owned real estate assets. We’ll now examine how this...

Euronet Worldwide (EEFT) is back in focus after a tough year marked by a 3Q25 earnings miss and short seller pressure, as digital money transfer transactions rose 32% year over year and margins expanded. See our latest analysis for Euronet Worldwide. The recent 4.4% 1 day share price return and 3.5% 7 day share price return to around $75.02 contrast with a 1 year total shareholder return decline of 22.6%. Short term momentum is improving while longer term holders remain under pressure as the...

Why this new colon cancer study matters for Guardant Health (GH) Guardant Health (GH) is back in focus after publishing, with Mayo Clinic and the Alliance for Clinical Trials in Oncology, the largest study so far using its Guardant Reveal blood test in resected stage III colon cancer. The Journal of Clinical Oncology paper reports that Guardant Reveal detected circulating tumor DNA in about 20% of more than 2,000 patients after surgery, identifying a group with a four to six times higher rate...

Smurfit Westrock plc recently declared a quarterly dividend of US$0.4523 per ordinary share, payable on March 18, 2026 to shareholders of record on February 17, 2026, while also updating investors that its issued share capital stands at 522,400,578 ordinary shares with full voting rights and announcing progress on Net Zero transition planning for its European recycled paper mills. Against this backdrop, attention is turning to the company’s upcoming February 11 earnings release, where mixed...

In early February 2026, Teradyne reported fourth-quarter 2025 earnings showing sales rising to US$1.08 billion and net income improving to US$257.22 million, while also issuing strong first-quarter 2026 guidance tied to accelerating AI-related demand in semiconductor testing. Alongside this, Teradyne and MultiLane agreed to form the MultiLane Test Products joint venture to develop high-speed test solutions for AI data center equipment, underscoring how AI infrastructure needs are reshaping...

Why Prosperity Bancshares (PB) is back in focus Prosperity Bancshares (PB) landed back on investors’ radar after its latest quarterly results, where higher net interest income and earnings coincided with rising net charge-offs and growing concern around credit quality. The market reaction has been shaped by a mix of positives, such as deposit growth and cost control, and pressure points including increased nonperforming assets and softer loan balances that raised fresh questions about...

Nordson (NDSN) is back on investors’ radar after management issued a positive sales and earnings outlook for fiscal 2026, along with a new US$1.2b credit facility and continued dividend growth signals. See our latest analysis for Nordson. Those stronger earnings, the fiscal 2026 outlook and the new US$1.2b credit facility have come alongside a clear pickup in momentum, with an 11.09% 1 month share price return, 23.60% 3 month share price return and a 37.33% 1 year total shareholder return...

Construction Partners, Inc. reported first‑quarter fiscal 2026 results on February 5, 2026, with revenue rising to US$809.47 million and net income improving to US$17.21 million, and it raised full‑year guidance to revenue of about US$3.48–3.56 billion and net income of US$154.0–158.0 million. Beyond the headline beat, the company’s record multi‑billion‑dollar backlog and recent Houston and Daytona Beach acquisitions expanded its footprint in key Sunbelt infrastructure markets. We’ll now...

Why FirstSun Capital Bancorp (FSUN) Is Back on Investors’ Radar FirstSun Capital Bancorp (FSUN) is drawing fresh attention after reporting full year 2025 results that paired higher net interest income and net income with a fourth quarter net charge off of US$5,024,000. For investors, this mix of stronger headline earnings and a clearly quantified credit cost creates a clearer starting point to assess how the bank is managing growth, risk, and capital allocation at the current share price. See...

Pinnacle Financial Partners recently announced that its board approved a US$0.50 per-share cash dividend for common shareholders, along with declared dividends on its Series A, B and C preferred stock, all payable in early 2026 to holders of record on specified February and March dates. This combination of common and preferred dividend declarations underscores the firm’s current capital-return posture and its willingness to distribute cash across its capital structure. We’ll now examine how...

Stock performance snapshot and recent context Blackbaud (BLKB) has been under pressure recently, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year. This may prompt some investors to reassess expectations. See our latest analysis for Blackbaud. At a share price of US$47.48, Blackbaud has seen pressure build over time, with a 30 day share price return of 23.68% and a 1 year total shareholder return of 39.17%. This suggests that...

Why Madison Square Garden Sports is in focus now Madison Square Garden Sports (MSGS) is back on investors’ radar after its latest quarterly earnings showed higher in-game revenues across ticketing, suites, sponsorship, and merchandise, supported by increased national media rights fees under new NBA deals. The company also highlighted benefits from updated local media agreements and team rosters. Management pointed to what it views as strong fundamentals and demand, which has helped draw fresh...

Q2 earnings outperformance puts MSGE in focus Madison Square Garden Entertainment (MSGE) has moved onto more investor watchlists after its latest quarterly results, where revenue, net income and earnings per share all came in above analyst expectations. See our latest analysis for Madison Square Garden Entertainment. The stronger than expected Q2 numbers sit alongside a solid recent run in the shares, with a 30 day share price return of 10.62% and a 90 day share price return of 23.50%. Over...

Why CME Group’s latest earnings matter for shareholders CME Group (CME) just released fourth quarter and full year 2025 results, giving you fresh numbers on how the futures exchange operator is performing and where its growth engines currently sit. The company reported fourth quarter revenue of US$1,648.7 million and net income of US$1,182.9 million, with diluted earnings per share from continuing operations of US$3.24. For the full year, revenue was US$6,520.6 million and net income reached...

GE HealthCare Technologies (NasdaqGS:GEHC) has expanded its Voluson ultrasound platform with AI-powered prenatal and fetal tools from BrightHeart's B-Right AI Platform and Diagnoly's Fetoly platform. Both AI solutions recently received FDA 510(k) clearance and CE Marking, supporting clinical use in multiple regions. The company also announced FDA clearance for its Allia Moveo interventional imaging system in cardiovascular and surgical imaging. GE HealthCare Technologies, trading at $80.65,...

Huntington Ingalls Industries (NYSE:HII) completed successful builder’s sea trials for the John F. Kennedy (CVN 79), its second Ford class aircraft carrier. The milestone marks a key step in moving CVN 79 closer to delivery and operational readiness for the U.S. Navy. The trials tested core ship systems at sea, highlighting progress in HII’s nuclear powered carrier program. For investors tracking defense contractors, this progress comes with HII shares trading around $397.77. The company...

Mondelez International (MDLZ) has put investors in reassessment mode after reporting Q4 results that beat expectations while guiding for 2026 organic net revenue growth of flat to 2%, citing cocoa volatility and cost pressures. See our latest analysis for Mondelez International. The latest earnings update and 2026 guidance arrive after a solid 11.87% year to date share price return and an 8.95% 1 month share price gain. At the same time, the 1 year total shareholder return of 5.93% and...

Cullen/Frost Bankers recently reported fourth-quarter and full-year 2025 results showing higher net interest income and net income year over year, alongside board approval of continued common and preferred dividends and a new US$300 million share repurchase program. The company also refreshed its board with the addition of experienced executives Marsha M. Shields and Jeff Rummel, while highlighting Texas-focused branch expansion, strong organic customer growth, and historically high levels...

Why Henry Schein Is Back on Investors’ Radar Henry Schein (HSIC) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past month and past 3 months prompting investors to reassess the stock’s current pricing. See our latest analysis for Henry Schein. At a share price of US$79.72, Henry Schein has recently seen stronger short term momentum, with a 1 day share price return of 3.53% and a 90 day share price return of 9.21%, while the 1 year total...

Tradeweb Markets (NasdaqGS:TW) has introduced fully electronic multi-asset package trading for USD-denominated swaps. The new workflow lets clients execute interest rate swaps and bonds together in a single electronic trade. This rollout extends Tradeweb's existing electronic trading capabilities across fixed income and derivatives. Tradeweb Markets, trading at $112.13, sits at the center of electronic fixed-income and derivatives trading, and this latest product builds on that role. The...

Fourth quarter earnings and dividend move draw investor focus Arthur J. Gallagher (AJG) is back in the spotlight after fourth quarter 2025 earnings showed higher revenue alongside lower quarterly net income and diluted EPS, paired with a fresh increase to its quarterly dividend. See our latest analysis for Arthur J. Gallagher. At a share price of $241.58, Arthur J. Gallagher has seen a 1 month share price return of an 8.70% decline and a 1 year total shareholder return of a 24.40% decline...

Sirius XM Holdings (SIRI) surprised investors with better than expected fourth quarter results, featuring record free cash flow, strong podcast revenue, a second consecutive quarter of self pay subscriber gains, and a record low churn rate. See our latest analysis for Sirius XM Holdings. Those results came after a sharp 9% to 10% jump on the earnings headline and a later 4.1% daily share price pullback. This reflected investors balancing improved cash generation against softer guidance and...